Cargando…
Complement in Pancreatic Disease—Perpetrator or Savior?
The complement system is a major pillar of the humoral innate immune system. As a first line of defense against pathogens, it mediates early inflammatory response and links different branches of humoral and cellular immunity. Disorders affecting the exocrine pancreas, such as acute pancreatitis, pot...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239781/ https://www.ncbi.nlm.nih.gov/pubmed/28144242 http://dx.doi.org/10.3389/fimmu.2017.00015 |
_version_ | 1782495946915971072 |
---|---|
author | Bettac, Lucas Denk, Stephanie Seufferlein, Thomas Huber-Lang, Markus |
author_facet | Bettac, Lucas Denk, Stephanie Seufferlein, Thomas Huber-Lang, Markus |
author_sort | Bettac, Lucas |
collection | PubMed |
description | The complement system is a major pillar of the humoral innate immune system. As a first line of defense against pathogens, it mediates early inflammatory response and links different branches of humoral and cellular immunity. Disorders affecting the exocrine pancreas, such as acute pancreatitis, potentially lead to a life-threatening systemic inflammatory response with aberrant activation of complement and coagulation cascades. Pancreatic proteases can activate key effectors of the complement system, which in turn drive local and systemic inflammation. Beyond that, the extent of pancreas–complement interaction covers complex pro- and anti-inflammatory mechanisms, which to this day remain to be fully elucidated. This review provides a comprehensive overview of the pathophysiological role of complement in diseases of the exocrine pancreas, based on existing experimental and clinical data. Participation of complement in acute and chronic pancreatitis is addressed, as well as its role in tumor immunology. Therapeutic strategies targeting complement in these diseases have long been proposed but have not yet arrived in the clinical setting. |
format | Online Article Text |
id | pubmed-5239781 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-52397812017-01-31 Complement in Pancreatic Disease—Perpetrator or Savior? Bettac, Lucas Denk, Stephanie Seufferlein, Thomas Huber-Lang, Markus Front Immunol Immunology The complement system is a major pillar of the humoral innate immune system. As a first line of defense against pathogens, it mediates early inflammatory response and links different branches of humoral and cellular immunity. Disorders affecting the exocrine pancreas, such as acute pancreatitis, potentially lead to a life-threatening systemic inflammatory response with aberrant activation of complement and coagulation cascades. Pancreatic proteases can activate key effectors of the complement system, which in turn drive local and systemic inflammation. Beyond that, the extent of pancreas–complement interaction covers complex pro- and anti-inflammatory mechanisms, which to this day remain to be fully elucidated. This review provides a comprehensive overview of the pathophysiological role of complement in diseases of the exocrine pancreas, based on existing experimental and clinical data. Participation of complement in acute and chronic pancreatitis is addressed, as well as its role in tumor immunology. Therapeutic strategies targeting complement in these diseases have long been proposed but have not yet arrived in the clinical setting. Frontiers Media S.A. 2017-01-17 /pmc/articles/PMC5239781/ /pubmed/28144242 http://dx.doi.org/10.3389/fimmu.2017.00015 Text en Copyright © 2017 Bettac, Denk, Seufferlein and Huber-Lang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Bettac, Lucas Denk, Stephanie Seufferlein, Thomas Huber-Lang, Markus Complement in Pancreatic Disease—Perpetrator or Savior? |
title | Complement in Pancreatic Disease—Perpetrator or Savior? |
title_full | Complement in Pancreatic Disease—Perpetrator or Savior? |
title_fullStr | Complement in Pancreatic Disease—Perpetrator or Savior? |
title_full_unstemmed | Complement in Pancreatic Disease—Perpetrator or Savior? |
title_short | Complement in Pancreatic Disease—Perpetrator or Savior? |
title_sort | complement in pancreatic disease—perpetrator or savior? |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239781/ https://www.ncbi.nlm.nih.gov/pubmed/28144242 http://dx.doi.org/10.3389/fimmu.2017.00015 |
work_keys_str_mv | AT bettaclucas complementinpancreaticdiseaseperpetratororsavior AT denkstephanie complementinpancreaticdiseaseperpetratororsavior AT seufferleinthomas complementinpancreaticdiseaseperpetratororsavior AT huberlangmarkus complementinpancreaticdiseaseperpetratororsavior |